Literature DB >> 26091510

Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.

Alyssa Fischer1, Ann A Jakubowski, Mario E Lacouture, Travis J Hollmann, Aaron M Drucker, Molly Maloy, Susan Prockop, Christiane Querfeld, Klaus J Busam, Melissa P Pulitzer.   

Abstract

T-cell-depleted (TCD) allogeneic hematopoietic stem cell transplantation demonstrates similar efficacy and reduced incidence and severity of graft-versus-host disease (GVHD) in appropriately selected patients versus T-cell-replete transplantation. The histopathology of cutaneous acute GVHD (aGVHD) after TCD peripheral blood stem cell transplants (PBSCTs) is not described. We identified 13 cases of patients after TCD PBSCT, with definitive aGVHD, and 20 cases of non-aGVHD skin rash in patients after TCD PBSCT, during multidisciplinary review by a dermatopathologist, dermatologist, and transplant physician, incorporating clinical presentation, therapeutic response, and histopathology data. Histopathologic features of aGVHD and non-aGVHD skin rash in TCD PBSCT patients were compared to each other, and also to features recently reported for non-TCD transplant recipients. aGVHD and non-aGVHD skin rash in TCD PBSCT patients' biopsies had similar rates of epidermal acanthosis, dermal melanophages, neutrophils, plasma cells, eosinophils, and extravasated erythrocytes. While satellitosis, exocytosis and adnexal involvement slightly favored aGVHD, more notable differential findings favoring aGVHD were diffuse (vs. focal/absent) basal vacuolization (77% aGVHD vs. 25% non-aGVHD rash), involvement of the entire epidermis (vs. partial thickness) by necrotic keratinocytes (42% aGVHD vs. 0% non-aGVHD rash), and nondense (rather than exuberant) inflammatory infiltrates (77% vs. 20%). After filtering features seen in all TCD samples (epidermal acanthosis, dermal melanophages, neutrophils, plasma cells, eosinophils, and extravasated erythrocytes), the most distinct features belonging to aGVHD-positive TCD samples were diffuse basal vacuolization, slight rather than dense inflammatory infiltrates, and necrotic keratinocytes involving the entire epidermis. Awareness of these features may help when evaluating a skin rash occurring after a TCD transplant.

Entities:  

Mesh:

Year:  2015        PMID: 26091510      PMCID: PMC4966921          DOI: 10.1097/DAD.0000000000000357

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  17 in total

1.  Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.

Authors:  C Vassallo; V Brazzelli; P E Alessandrino; M Varettoni; M Ardigò; M Lazzarino; G Borroni
Journal:  Br J Dermatol       Date:  2004-09       Impact factor: 9.302

2.  Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.

Authors:  N Novitzky; V Thomas; G Hale; H Waldmann
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

3.  T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.

Authors:  Ann A Jakubowski; Trudy N Small; Nancy A Kernan; Hugo Castro-Malaspina; Nancy Collins; Guenther Koehne; Katharine C Hsu; Miguel A Perales; Genovefa Papanicolaou; Marcel R M van den Brink; Richard J O'Reilly; James W Young; Esperanza B Papadopoulos
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

4.  Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.

Authors:  K G Lerner; G F Kao; R Storb; C D Buckner; R A Clift; E D Thomas
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

5.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

6.  Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions.

Authors:  Joshua Weaver; Wilma F Bergfeld
Journal:  Am J Dermatopathol       Date:  2010-02       Impact factor: 1.533

7.  The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.

Authors:  Daniela Massi; Cristina Fondi; Chiara Nozzoli; Silvia Benemei; Francesco Lapi; Luca Albarello; Claudio Avellini; Emanuela Bonoldi; Marco Casini; Anna Maria Cesinaro; Fabio Ciceri; Vito Colombetti; Camilla Eva Comin; Amedea Donelli; Mirella Fortunato; Stefano Fratoni; Stefano Guidi; Luca Messerini; Giuseppe Milone; Davide Rapezzi; Giovanni Negri; Francesca Patriarca; Fedro Alessandro Peccatori; Maurilio Ponzoni; Paola Rafaniello; Roberto Raimondi; Edvige Salomone; Andrea Tendas; Loredana Villari; Marco Santucci; Alberto Bosi
Journal:  Hum Pathol       Date:  2010-11-24       Impact factor: 3.466

8.  Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.

Authors:  Steven M Devine; Shelly Carter; Robert J Soiffer; Marcelo C Pasquini; Parameswaran N Hari; Anthony Stein; Hillard M Lazarus; Charles Linker; Edward A Stadtmauer; Edwin P Alyea; Carolyn A Keever-Taylor; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2011-02-12       Impact factor: 5.742

9.  T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.

Authors:  Ann A Jakubowski; Trudy N Small; James W Young; Nancy A Kernan; Hugo Castro-Malaspina; Katherine C Hsu; Miguel-Angel Perales; Nancy Collins; Christine Cisek; Michelle Chiu; Marcel R M van den Brink; Richard J O'Reilly; Esperanza B Papadopoulos
Journal:  Blood       Date:  2007-08-23       Impact factor: 22.113

10.  T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.

Authors:  Jenna D Goldberg; Alex Linker; Deborah Kuk; Ravin Ratan; Joseph Jurcic; Juliet N Barker; Hugo Castro-Malaspina; Sergio Giralt; Katharine Hsu; Ann A Jakubowski; Robert Jenq; Guenther Koehne; Esperanza B Papadopoulos; Marcel R M van den Brink; James W Young; Farid Boulad; Nancy A Kernan; Richard J O'Reilly; Susan E Prockop; Joachim Yahalom; Glenn Heller; Miguel-Angel Perales
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-13       Impact factor: 5.742

View more
  6 in total

1.  Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.

Authors:  Nicholas Aj Dawson; Caroline Lamarche; Romy E Hoeppli; Peter Bergqvist; Vivian Cw Fung; Emma McIver; Qing Huang; Jana Gillies; Madeleine Speck; Paul C Orban; Jonathan W Bush; Majid Mojibian; Megan K Levings
Journal:  JCI Insight       Date:  2019-03-21

2.  Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions.

Authors:  Anthony J Deegan; Faezeh Talebi-Liasi; Shaozhen Song; Yuandong Li; Jingjiang Xu; Shaojie Men; Michi M Shinohara; Mary E Flowers; Stephanie J Lee; Ruikang K Wang
Journal:  Lasers Surg Med       Date:  2018-01-22       Impact factor: 4.025

3.  Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation.

Authors:  Skylar Klager; Mario E Lacouture; Margaret Hannum; Sean M Devlin; Molly Maloy; Melissa Pulitzer; Ann A Jakubowski; Alina Markova
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-12       Impact factor: 5.742

4.  Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.

Authors:  Rachel E Reingold; Jilliana Monnier; Marco Ardigò; Joseph R Stoll; Maria C Pena; Japbani K Nanda; Stephen W Dusza; Josel D Ruiz; Lisa Flynn; Antara Afrin; Elizabeth G Klein; Susan E Prockop; Melissa P Pulitzer; Doris M Ponce; Alina Markova; Manu Jain
Journal:  Transplant Cell Ther       Date:  2021-09-24

5.  Immune cell subsets in interface cutaneous immune-related adverse events associated with anti-PD-1 therapy resemble acute graft versus host disease more than lichen planus.

Authors:  Guillermo E Almodovar Cruz; Genevieve Kaunitz; Julie E Stein; Inbal Sander; Travis Hollmann; Tricia R Cottrell; Janis M Taube; Joel C Sunshine
Journal:  J Cutan Pathol       Date:  2022-05-16       Impact factor: 1.458

6.  Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience.

Authors:  Stuart S Kaufman; Elsadig Hussan; Alexander Kroemer; Olga Timofeeva; Helena B Pasieka; Juan Francisco Guerra; Nada A Yazigi; Khalid M Khan; Udeme D Ekong; Sukanya Subramanian; Jason S Hawksworth; Raffaelle Girlanda; Shahira S Ghobrial; Thomas M Fishbein; Cal S Matsumoto
Journal:  Transplant Direct       Date:  2021-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.